Literature DB >> 26321022

A manic episode with psychotic features improved by methylprednisolone in a patient with multiple sclerosis.

Sevan Hotier1, David Maltete2, Bertrand Bourre2, Xavier Jegouzo3, Valérie Bourgeois3, Olivier Guillin3.   

Abstract

Several studies have reported a higher prevalence of unipolar depression and bipolar disorder among patients with multiple sclerosis (MS). However, only a few studies have reported manic episodes concomitant with new lesions enhanced by gadolinium on brain magnetic resonance imaging (MRI). Here we report the case of a 47-year-old woman suffering from MS admitted for a manic episode with psychotic features. Brain MRI revealed three new T2 lesions enhanced by gadolinium located in the corpus callosum and in ventromedial prefrontal regions. She rapidly recovered with intravenous methylprednisolone in combination with risperidone. In conclusion, in this patient, the fact that gadolinium-enhancing lesion coincided with new symptoms which responded quickly to corticosteroids suggests that the manic episode was an acute manifestation of MS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Corticosteroids; Manic state; Multiple Sclerosis; Orbitofrontal; Psychosis

Mesh:

Substances:

Year:  2015        PMID: 26321022     DOI: 10.1016/j.genhosppsych.2015.07.002

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  2 in total

Review 1.  Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.

Authors:  Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Meghan Beier; Jodie K Haselkorn; Alicia P Sloan; Dawn M Ehde
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

Review 2.  Psychiatric event in multiple sclerosis: could it be the tip of the iceberg?

Authors:  Moussa A Chalah; Samar S Ayache
Journal:  Braz J Psychiatry       Date:  2017-03-23       Impact factor: 2.697

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.